Sherbrooke Park Advisers’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-13,495
Closed -$557K 317
2025
Q3
$557K Sell
13,495
-11,348
-46% -$456K 0.26% 138
2025
Q2
$1.09M Buy
24,843
+10,649
+75% +$426K 0.48% 32
2025
Q1
$524K Sell
14,194
-17,844
-56% -$636K 0.24% 125
2024
Q4
$1.07M Buy
32,038
+737
+2% +$23.9K 0.34% 41
2024
Q3
$812K Buy
+31,301
New +$778K 0.19% 129
2024
Q2
Sell
-8,696
Closed -$206K 998
2024
Q1
$206K Sell
8,696
-2,296
-21% -$51K 0.04% 715
2023
Q4
$264K Sell
10,992
-84,326
-88% -$1.83M 0.12% 274
2023
Q3
$2.08M Buy
95,318
+59,518
+166% +$1.24M 0.66% 13
2023
Q2
$684K Buy
+35,800
New +$690K 0.36% 98
2023
Q1
Sell
-43,100
Closed -$691K 227
2022
Q4
$691K Buy
+43,100
New +$703K 0.51% 62

Other funds holding EXEL

Sherbrooke Park Advisers's EXEL Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Exelixis (EXEL) in Q4 2025, closing a stake of 13,495 shares — an estimated $557K sold.

Sherbrooke Park Advisers first reported a position in EXEL in Q4 2022 and held it in 10 quarters. The position peaked at $2.08M in Q3 2023. 685 funds tracked by Wall St. Rank hold EXEL as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Exelixis position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 13,495 Exelixis shares in Q4 2025, an estimated $557K.
  • Sherbrooke Park Advisers first reported a position in Exelixis in Q4 2022 and held it in 10 quarters.
  • Sherbrooke Park Advisers's Exelixis position peaked at $2.08M in Q3 2023.
  • 685 funds tracked by Wall St. Rank held Exelixis as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.